The medical technology landscape in 2026 is defined by a paradigm shift from pandemic-era stabilisation to a focused era of precision consolidation. This period represents the maturation of several long-term technological trajectories, most notably artificial intelligence, neurotechnology, and minimally invasive surgical platforms, converging with a significant recalibration of capital markets and regulatory frameworks. As the […]
